infections

ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

May 11, 2026 04:00 ET  | Source: ENA Respiratory MELBOURNE, Australia, May 11, 2026 (GLOBE NEWSWIRE) -- ENA Respiratory, a…

2 weeks ago

Apollo Hospitals introduces first of its kind advanced bone regeneration solution for diabetic and complex bone infections

Aims to reduce amputations and improve recovery outcomes for high-risk patientsHYDERABAD, India, May 5, 2026 /PRNewswire/ -- Reinforcing its commitment to…

3 weeks ago

PIVOT-PO Phase 3 Data Show Tebipenem HBrs Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared…

7 months ago